What 519 GLP-1 Signup Funnels Look Like

Reading a seller’s website tells you what it claims. Walking its signup funnel tells you what it does. We have walked 519 of them, one at a time, recording the date each time — and the single most consistent difference between sellers is not price or product. It is whether they tell you the price before or after you hand over your health information.

Where the price appears

Of 519 funnels walked, 362 showed a price before the intake began. 157 — almost exactly 30% — showed nothing until the questionnaire was complete.

That split is the most useful single fact we hold about this market. It divides sellers into ones you can comparison-shop and ones you cannot, and it does so before any question of quality arises. A price you can only obtain by submitting medical details is not a price you can compare; it is a price you are shown once you are already invested.

Seventy percent will tell you. The remaining thirty percent want your health history first.

What a walk actually involves

We stop before any account is created, before payment, and before personal health data is submitted — which is why some funnels can only be characterized so far. What the walk records is the shape: how many steps, when the price appears, whether a live clinician visit is required, whether bloodwork is asked for, and how support can be reached.

That last one is worth its own note. Contact details were recorded for 343 sellers, and the most common form by far is an email address. A market that sells a prescription medication mostly supports it by email.

Video visits, honestly reported

This is where we have to be careful about what we actually know. The requires-a-video-visit question was answerable in only 94 of the 519 walks. Among those 94, 63 required one and 31 did not.

It would be easy and wrong to turn that into “63 of 556 sellers require a video visit”, because that phrasing implies we established the other 493 do not. We did not. What can be said is narrower: where the funnel made it clear, roughly two thirds required a live visit — which is a more encouraging picture than the market’s reputation suggests, drawn from a sample we cannot prove is representative.

The state-list problem

Separately from the funnel walks, 324 of 556 sellers publish no list of the states they serve. A clear majority.

This matters more than it sounds. A telehealth prescription must come from a clinician licensed in your state, so which states a seller operates in is not marketing detail — it is the thing that determines whether it can legally treat you at all. Among the sellers that do publish a list, coverage skews the way populations do: Texas, Florida and Arizona appear most often, while Mississippi, Arkansas, Alaska and Hawaii appear least. The District of Columbia is served by a small fraction of them.

If you live somewhere less commonly served, the practical consequence is that the published lists are worth more to you than to anyone else — and a seller that will not publish one is asking you to find out during intake.

How to use this before you sign up

1. Find the price before starting an intake. If you cannot, note that you are in the 30% and let it weigh on the decision.
2. Check whether your state is listed before answering any medical question. A majority of sellers will not tell you, which is itself informative.
3. Notice whether a live visit is required. Slower is usually more careful here.
4. Look at how support is reached. An email address is the norm; a phone number is a meaningful upgrade when something goes wrong.
5. Stop at the first medical question if the basics are still missing. Price, states and pharmacy should all be answerable before you disclose anything.

Our comparison tool filters on what each seller publishes, which is the fastest way to skip the gated 30% entirely.